Brian Park, PharmD

All articles by Brian Park, PharmD

Enhertu Approved to Treat HER2-Positive Breast Cancer Following 2 or More Prior Anti-HER2 Therapies

By

Brian Park, PharmD

January 2, 2020

The US FDA has granted accelerated approval to Enhertu for the treatment of some adults with unresectable or metastatic HER2-positive breast cancer.

Next post in Breast Cancer

A patient and clinician review mammography results.

Removing Barriers to Optimal Breast Cancer Screening May Improve Overall Survival